Introduction: Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) can improve survival for patients with peritoneal surface malignancy. Completeness of cytoreduction correlates with prognosis. The role of gastrectomy in these patients is not well described.

Methods: 1868 patients who underwent CRS+HIPEC for non-gastric primary between 1991-2024 were analyzed from a prospective database. Patients were stratified by gastrectomy extent and their outcomes compared with no-gastrectomy patients. Continuous variables are presented as mean (SD), categorical variables as N (%) and values considered statistically significant at < 0.05.

Results: There were no differences in baseline demographics between the gastrectomy and no-gastrectomy groups. There were 23 major, 45 distal, and 77 wedge gastrectomies (n=145, 7.76%). Appendiceal was the most common neoplasm in the gastrectomy groups (major: 96%, distal: 91%, wedge: 68%, no gastrectomy: 53%). Gastrectomy patients had higher median PCI [major: 27(7.0), distal: 24(7.0), wedge: 19(10.3), no-gastrectomy: 14(9.5); p<0.001], R2 resection (major: 96%, distal: 89%, wedge: 60%, no-gastrectomy: 45%; p<0.001), severe complications (major: 30%, distal: 27%, wedge: 19%, no-gastrectomy: 12%; p<0.001), LOS [major: 24(15.2) , distal: 23(25.7), wedge: 18(22.2), no-gastrectomy: 12 (12.5) days; p<0.001], and 30-day mortality (major: 17%, distal: 11%, wedge: 10%, no-gastrectomy: 5%; p<0.001). There was no difference in 30-day readmission or recurrence. On multivariate analysis, gastrectomy was not independently associated with overall survival (OS) (p=0.18).

Conclusion: 8% of patients who underwent CRS+HIPEC for non-gastric primaries underwent gastrectomy. Gastrectomy patients were more likely to have higher PCI and incomplete resections with increased complications and mortality. PCI, resection status, LN's, tumor grade, and primary site, but not gastrectomy type, are significantly associated with OS.

Download full-text PDF

Source
http://dx.doi.org/10.1097/XCS.0000000000001292DOI Listing

Publication Analysis

Top Keywords

cytoreductive surgery
8
hyperthermic intraperitoneal
8
intraperitoneal chemotherapy
8
gastrectomy patients
8
groups major
8
patients
6
gastrectomy
6
outcomes gastrectomy
4
gastrectomy cytoreductive
4
surgery hyperthermic
4

Similar Publications

Background: Prediction of open-close and long-term outcome is challenging in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prognostic scores often include factors not known at baseline. Therefore, we aimed to analyze whether patterns of preoperative tumor markers could aid in prediction of open-close surgery and outcome in patients with pseudomyxoma peritonei (PMP) or colorectal peritoneal metastases (PM).

View Article and Find Full Text PDF

Background: Hematologic changes after splenectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) can complicate postoperative assessment of infection. This study aimed to develop a machine-learning model to predict postoperative infection after cytoreductive surgery (CRS) and HIPEC with splenectomy.

Methods: The study enrolled patients in the national TriNetX database and at the Johns Hopkins Hospital (JHH) who underwent splenectomy during CRS/HIPEC from 2010 to 2024.

View Article and Find Full Text PDF

Introduction: Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) can improve survival for patients with peritoneal surface malignancy. Completeness of cytoreduction correlates with prognosis. The role of gastrectomy in these patients is not well described.

View Article and Find Full Text PDF

SummaryWe report a case of small cell carcinoma of the ovary, hypercalcaemic type, a rare and aggressive form of ovarian cancer, causing an acute kidney injury. A woman in her mid-30s presented with a large pelvic mass and abdominal distention, this was associated with rapidly deteriorating renal function, which did not improve with standardised kidney injury treatment. There was a high suspicion of ovarian cancer.

View Article and Find Full Text PDF

Novel technique and outcomes of umbilical reconstruction during cytoreductive surgery; a multi-centre study.

Tech Coloproctol

January 2025

Peritonectomy and Liver Cancer Unit, Department of Surgery, St George Hospital, Kogarah, NSW, Australia.

Background: The goal of cytoreductive surgery for peritoneal malignancy is to remove all macroscopic disease, which occasionally requires the excision of the umbilicus. While the absence of the umbilicus can be aesthetically undesirable for patients, umbilical reconstruction is rarely performed due to the perceived complexity and increased risk of wound infections (Sakata et al. in Colorectal Dis 23:1153-1157, 2021).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!